z-logo
Premium
Intracellular Modulation of Excited‐State Dynamics in a Chromophore Dyad: Differential Enhancement of Photocytotoxicity Targeting Cancer Cells
Author(s) -
Kolemen Safacan,
Işık Murat,
Kim Gyoung Mi,
Kim Dabin,
Geng Hao,
Buyuktemiz Muhammed,
Karatas Tugce,
Zhang XianFu,
Dede Yavuz,
Yoon Juyoung,
Akkaya Engin U.
Publication year - 2015
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.201411962
Subject(s) - photosensitizer , singlet oxygen , intersystem crossing , photochemistry , photodynamic therapy , intracellular , chromophore , chemistry , cancer cell , biophysics , reactive oxygen species , excited state , oxygen , singlet state , biochemistry , cancer , biology , organic chemistry , physics , nuclear physics , genetics
The photosensitized generation of reactive oxygen species, and particularly of singlet oxygen [O 2 (a 1 Δ g )], is the essence of photodynamic action exploited in photodynamic therapy. The ability to switch singlet oxygen generation on/off would be highly valuable, especially when it is linked to a cancer‐related cellular parameter. Building on recent findings related to intersystem crossing efficiency, we designed a dimeric BODIPY dye with reduced symmetry, which is ineffective as a photosensitizer unless it is activated by a reaction with intracellular glutathione (GSH). The reaction alters the properties of both the ground and excited states, consequently enabling the efficient generation of singlet oxygen. Remarkably, the designed photosensitizer can discriminate between different concentrations of GSH in normal and cancer cells and thus remains inefficient as a photosensitizer inside a normal cell while being transformed into a lethal singlet oxygen source in cancer cells. This is the first demonstration of such a difference in the intracellular activity of a photosensitizer.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here